News & Media

DiscoveryBioMed, Inc. announces a new internship program for 2016

DiscoveryBioMed, Inc. (DBM, Inc.) is pleased to announce the initiation of a new internship program in conjunction with the University of Alabama at Birmingham (UAB) that will begin in January 2016.

DiscoveryBioMed, Inc. (DBM, Inc.) is pleased to announce the initiation of a new internship program in conjunction with the University of Alabama at Birmingham (UAB) that will begin in January 2016.

DBM’s Dr. Erik Schwiebert directs and teaches the first introductory class called “Idea to IPO” in a Technology Entrepreneurship Certificate program and a series of courses focused on entrepreneurship on behalf of the Collat School of Business at UAB. Moreover, DBM is a local industry partner for a new UAB Experiences program directed by Dr. Lisa Marshall Schwiebert, Ph.D. and Jami Armbrester, MS that is funded by Burroughs-Wellcome and for a Design and Commercialization program in UAB’s Biomedical Engineering division directed by Dr. Alan Eberhart, Ph.D.

“I attended these classes when I was a faculty member at UAB when the idea was incubating for DiscoveryBioMed, Inc. Shortly after DBM was founded, I was alerted to the fact that these classes needed a new instructor so I volunteered and we had the class at Innovation Depot for the first years of re-starting them,” explained Dr. Schwiebert. Erik began directing and teaching the class in the Fall of 2009 and this course completed another class semester this Fall of 2015, the 7th Idea to IPO class. This Fall of 2015, DBM also presented a Biotechnology Boot Camp for the new UAB Experiences program that was well attended. During this intensive session, principles of entrepreneurship, differences between basic and applied science, and opportunities in biotechnology in the Birmingham region and across Alabama were highlighted. “DBM continues in these biotechnology entrepreneurship education efforts because a critical mass of new biotechnology entrepreneurs and new companies not only helps Birmingham become a hub for biotechnology but it also helps DBM and, in return, DBM can help newer companies,” declared Dr. Schwiebert. “It is a win-win and we need to be more free and creative in spawning new UAB startups.”

From the Idea to IPO class and from the active UAB programs this Fall, we have a series of part-time interns who will be exposed to DBM during a typical week or that will work with DBM for multiple days during a week during Q1 2016 and/or H1 2016.

DBM will have more details about these interns and the program in 2016.

Return to All News

Leave a Reply